Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jingfang Mixture for acute upper respiratory tract infection (wind-cold syndrome)
ChiCTR2200066099Phase 4Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of jingfang mixture in upper respiratory infection (URI) (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Symptom resolution time. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
jingfang mixture
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR2200066099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066099.